Furthermore, mutations in the mitochondrial fusion gene MFN2 have been linked both to multiple symmetric lipomatosis and to features of MetS (6, 7), suggesting a potential biological bridge between localized lipoma formation and systemic metabolic disease. This evidence concerns the gene MFN2 and lipomatosis.